Amy Proal
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Amy Danielle Proal, PhD, is a microbiologist who researches the role of the human microbiome and human virome in chronic inflammatory disease.[1] Proal works at the PolyBio Research Foundation, California.
Notable studies[edit | edit source]
- 2013, Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis[2] - (Abstract)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity[3] - (Full text)
Talks and interviews[edit | edit source]
- Nov 15, 2019 - ME/CFS in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering with Host Metabolism, Gene Expression, and Immunity, a Solve M.E. Webinar
Online presence[edit | edit source]
- Microbe Minded blog
- PubMed
- Website
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "About Amy | Microbe Minded". Retrieved February 2, 2019.
- ↑ Proal, Amy D.; Albert, Paul J.; Marshall, Trevor G.; Blaney, Greg P.; Lindseth, Inge A. (July 1, 2013). "Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis". Immunologic Research. 56 (2): 398–412. doi:10.1007/s12026-013-8413-z. ISSN 1559-0755.
- ↑ Proal, Amy; Marshall, Trevor (November 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity". Frontiers in Pediatrics. doi:10.3389/fped.2018.00373.
